Skip to main content

Controlling viral aerosols in COVID-19 and beyond

Objective

Protecting healthcare staff and preserving key clinical practice is a key WHO priority area for the immediate term in the COVID-19 pandemic, and also after peak crisis in the new practice landscape with population prevalence. Surgery is a key therapy for emergency patients and for cancer care and cardiac disease among others. It also is the hallmark aerosolising intervention, risking viral transmission to many staff, not only during the procedure itself, but also during other interventional procedures including bedside episodic procedures such as intubation for ventilation or nasogastric tube drainage. Recent guidance has suggested abandoning keyhole surgery access, despite its cornerstone role in emergency and cancer therapy, its myriad benefits to patients, and the fact that a whole generation of surgeons would need retraining in open surgery to accomplish this safely. Laparoscopic surgery uses gas to distend a body cavity to make space for a camera and instruments to be inserted and worked by a surgical team. This gas is emptied from the patient by opening valves in the access instrumentation which typically enters the operating room (OR). The risks of venting gas can be addressed technologically by using more sophisticated and emerging insufflation technology. However this does not address leaks during endotracheal tube placement, leaks that occur around the trocar, leaks during endoscopy or leaks from the anus during transanal surgery. This project will a) characterise the nature of these gas leaks using specialized imaging technology, b) develop vacuum devices to entrain and filter such leaks c) validate the effectiveness of the devices clinically, complete CE mark certification and e) deploy to surgery centres worldwide.

Field of science

  • /medical and health sciences/clinical medicine/surgery
  • /engineering and technology/environmental engineering/energy and fuels/fossil energy/gas
  • /medical and health sciences/clinical medicine/oncology/cancer

Call for proposal

H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
See other projects for this call

Funding Scheme

IA - Innovation action

Coordinator

PINTAIL LTD
Address
Springhill Avenue 77
A94 K542 Blackrock
Ireland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 108 500

Participants (4)

PALLIARE LIMITED
Ireland
EU contribution
€ 924 525
Address
2 Grand Canal Square
D02 A342 Dublin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Ireland
EU contribution
€ 461 360
Address
Belfield
4 Dublin
Activity type
Higher or Secondary Education Establishments
INSTITUT DE RECHERCHE CONTRE LES CANCERS DE L'APPAREIL DIGESTIF
France
EU contribution
€ 448 740
Address
Place De L'hopital 1
67091 Strasbourg Cedex
Activity type
Research Organisations
STERIPACK MEDICAL POLAND SP ZOO
Poland
EU contribution
€ 295 575
Address
Ul. Japonska 1 Leg
55 220 Jelcz Laskowice
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)